Anti-Silicone Implant Media Campaign, Rally Planned By Consumer Groups
This article was originally published in The Gray Sheet
Executive Summary
A petition from Public Citizen appears to have persuaded FDA to disclose the General & Plastic Surgery Devices Panel roster nearly two weeks before the panel's review of a silicone gel breast implant premarket application
You may also be interested in...
FDA Aims To Up Transparency By Making Panel Materials Public Sooner
FDA will post advisory committee briefing materials on its Web site at least two business days in advance of meetings, doubling the current lead time in an effort to enhance transparency, according to a 1draft guidance released last week
FDA Aims To Up Transparency By Making Panel Materials Public Sooner
FDA will post advisory committee briefing materials on its Web site at least two business days in advance of meetings, doubling the current lead time in an effort to enhance transparency, according to a 1draft guidance released last week
FDA Advisory Panel CoI Statements Should Be More Transparent – NEJM
FDA may need to change its conflict-of-interest policies for advisory panels, a column in the July 14 New England Journal of Medicine proposes